NCT05023499
- Conditions
- Body Weight, Body Weight Changes, Cachexia, +15 more
- Locations
-
Not specified
Clinical trial condition
Cachexia
Explore clinical trials studying Cachexia. Study availability and eligibility vary by location and protocol.
104 public trials
18 recruiting studies
Cachexia trial results
Completed
Skeletal Muscle Wasting in SARS-CoV-2
NCT04698798
- Conditions
- Atrophy, Body Weight, Body Weight Changes, +16 more
- Locations
-
- Jessa Ziekenhuis Hasselt, Belgium
NCT04802486
- Conditions
- Behavior, Body Weight, Body Weight Changes, +13 more
- Locations
-
- University of Rochester Rochester, New York, United States
NCT00698828
- Conditions
- Body Weight, Body Weight Changes, Cachexia, +11 more
- Locations
-
- Waterbury Pulmonary Associates Waterbury, Connecticut, United States
- Clinical Research of West Florida Clearwater, Florida, United States
- Innovative Research of West Florida Largo, Florida, United States
- The Center for Clinical Research, Washington County Hospital Hagerstown, Maryland, United States
NCT03207724
- Conditions
- Adenocarcinoma, Body Weight, Body Weight Changes, +19 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
NCT02442908
- Conditions
- Body Weight, Body Weight Changes, COPD, +12 more
- Locations
-
- Ladulaas kliniska studier Borås, Sweden
- Pharmasite Helsingborg, Sweden
- Pharmasite Malmö, Sweden
- A+ Science City Site Stockholm, Sweden
NCT04631978
- Conditions
- Body Weight, Body Weight Changes, Cachexia, +5 more
- Locations
-
- Aslı Çentinkaya Yaprak Antalya, Turkey (Türkiye)
NCT02400398
- Conditions
- Body Weight, Body Weight Changes, Cachexia, +13 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
NCT03359473
- Conditions
- Body Weight, Body Weight Changes, Cachexia, +17 more
- Locations
-
- GSK Investigational Site Torrance, California, United States
- GSK Investigational Site Jacksonville, Florida, United States
- GSK Investigational Site High Point, North Carolina, United States
- GSK Investigational Site Philadelphia, Pennsylvania, United States
NCT00866970
- Conditions
- Body Weight, Body Weight Changes, Cachexia, +13 more
- Locations
-
- Rivercity Hospital Research Centre Auchenflower, Queensland, Australia
- Australian Clinical Research Organisation Kippa-Ring, Queensland, Australia
- Royal Adelaide Hospital Adelaide, South Australia, Australia
- Palliative Care Launceston General Hospital Launceston, Tasmania, Australia